Dr Shi Luming
MBBS, MSc (Clinical Sciences), MSc (Health Economics and Pharmacoeconomics)
Head of Epidemiology, SCRI
Adjunct Assistant Professor, Duke-NUS Graduate Medical School Singapore
Member, Cochrane Singapore
Dr Shi Luming is the Head of Epidemiology at SCRI. She has more than 20 years of experience in healthcare industry with core competence in research methodology, evidence-based medicine, public health, quantitative medicine, healthcare management, and disease surveillance. Dr Shi earned her MBBS in 1993, completed her MSc in Clinical Sciences in 2002 and further pursued her MSc in Health Economics and Pharmacoeconomics in 2008. From 2010 to 2013, she was a senior epidemiologist at the Ministry of Health. Dr Shi holds a dual appointment as an Adjunct Assistant Professor at Duke-National University of Singapore Graduate Medical School. She is also a member of the Cochrane Singapore.
- Clinical research and health services research
- Evidence-based medicine
- Public Health policy
- Health economic evaluation
- Systematic review and meta-analysis
- Observational epidemiological studies
- Lim KC, Wang VW, Siddiqui FJ, Shi LM, Chan SYE, Oh HC, Tan SB, Chow PKH. Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria. Hepatology. 2015 Jan;61(1):227-37.?
- Tan WS, Tang CL, Shi L, Eu KW. Meta-analysis of defunctioning stomas in low anterior resection for rectal cancer. Br J Surg. 2009 May; 96(5):462-72.
- Chia SE, Shi LM, Chan OY, Chew SK, Foong BH. Parental occupations and other risk factors associated with nonchromosomal single, chromosomal single, and multiple birth defects: A population-based study in Singapore from 1994 to 1998. Am J Obstet Gynecol 2003; 108:425-433.